Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04473625 · ClinicalTrials.gov registry record
Stool Collection Sub-Study of Exact Sciences Protocol 2018-01
A clinical trial, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 291
- Enrollment target
NCT04473625: Completed study, sponsored by Exact Sciences Corporation.
NCT04473625 is a clinical trial that has completed, run by Exact Sciences Corporation. The registered enrollment target is 291 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04473625 has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 291 participants
- Enrollment target
Study Summary
The primary objective of this sub-study is to obtain de-identified, clinically characterized, stool specimens from subjects with untreated solid tumors for research use in the development and validation of a stool-based test for colorectal cancer.
Primary Outcome
Research for the development and validation of a stool-based test for colorectal cancer
Interventions
- OTHER Stool Sample Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2020-07-21 |
| Est. Completion | 2022-05-25 |
What the finished NCT04473625 record still lists
NCT04473625 is an observational study that tracks outcomes without assigning an intervention. The registered 291 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Stool Sample Collection is the first listed.
NCT04473625 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04473625 about?
NCT04473625 is a clinical study titled "Stool Collection Sub-Study of Exact Sciences Protocol 2018-01". The primary objective of this sub-study is to obtain de-identified, clinically characterized, stool specimens from subjects with untreated solid tumors for research use in the development and validation of a stool-based test for colorectal cancer.
What is the current status of trial NCT04473625?
This trial is currently completed. The enrollment target is 291 participants. The study started on 2020-07-21. Estimated completion is 2022-05-25.
What interventions are being tested in trial NCT04473625?
The interventions under investigation include: Stool Sample Collection (OTHER).
Who is sponsoring clinical trial NCT04473625?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02074839 · 291 participants · Phase 1
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- NCT03769766 · 291 participants · Phase 3
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
- NCT06563479 · 291 participants · Phase 3
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
- NCT04429542 · 292 participants · Phase 1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI